Delivery Order 75F40123D00039-75F40126F19003

The Food and Drug Administration issued a delivery order to Battelle Memorial Institute on September 29, 2021, with a ceiling value of $2,021,201 to investigate whether machine-generated nicotine yield from electronic nicotine delivery systems can predict human nicotine exposure. The order was modified on September 29, 2025, to revise the biosamples storage timeline from one year after submission of the clinical report to one year after the end of data collection (February 2025). This is a...

This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $3,872,713 task order, which is not set aside, is for a study to evaluate whether reductions in biomarkers of exposure, biomarkers of potential harm, and other health risk markers are proportional to reductions in cigarette smoking when switching to electronic nicotine delivery systems. Lovelace...

The Food and Drug Administration issued a delivery order to Labstat International Inc. on September 3, 2024, with a ceiling value of $802,650.92 under a firm fixed-price structure for chemical characterization of e-liquid and aerosol of electronic nicotine delivery systems containing non-tobacco nicotine. The order is issued under the FDA's $45 million single-award IDIQ contract for tobacco laboratory analysis and engineering services, awarded January 18, 2022, with ultimate completion January...

This is a delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit organization, for a project titled "CYTOTOXICITY OF COMMON SOLVENTS USED IN LIQUID NICOTINE FORMULATIONS". The contract has a potential value of $1,149,919.00 and a completion date of April 15, 2021. This delivery order is part of a larger indefinite delivery/indefinite quantity...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order valued at forty-six thousand three hundred fifty dollars to Enthalpy Analytical, LLC of Calverton, Maryland. The delivery order was issued on March 16, 2020 under the parent company Montrose Environmental Group, Inc. and calls for Enthalpy Analytical to conduct a project review of particle size distribution and coil temperature for electronic nicotine delivery systems. Specifically,...

This is a firm fixed-price delivery order issued by the Department of Health and Human Services Food and Drug Administration under the In Vivo Toxicology of Tobacco 2015-2020 indefinite delivery/indefinite quantity (IDIQ) contract. The $1,408,956.00 task order was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to perform detection and characterization of DNA adducts generated by tobacco flavorants in aerosol...

The Food and Drug Administration awarded a $38.8 million definitive contract to Lovelace Biomedical Research Institute on September 26, 2019, for a study of e-cigarette aerosol toxicity in in vivo nonclinical models, with firm fixed price terms. The contract, posted August 21, 2019, with ultimate completion on June 30, 2025, is now in deobligation/closeout status. Place of performance is Silver Spring, MD. Service Contract Inventory reporting shows Lovelace invoiced $5.4 million in FY2020,...

The Food and Drug Administration (FDA) awarded a $3.4M firm fixed-price contract to The Fox Foundation Inc. on September 24, 2024, to conduct a clinical laboratory study investigating the abuse liability of electronic nicotine delivery systems (ENDS) formulated with non-tobacco nicotine (NTN) compared to tobacco-derived nicotine (TDN). The three-year contract, which extends through September 2027, requires The Fox Foundation to execute a randomized, double-blinded, within-subjects crossover...

This is a $77,377.03 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to GD USA Inc., a foreign-owned, for-profit, woman-owned manufacturer, to provide an electronic cigarette smoking machine and related services. The contract was set aside for small businesses. The machine will be used by the FDA's Forensic Chemistry Center to automatically smoke electronic cigarettes and collect vapors for offline chemical analysis, supporting the FDA's regulatory oversight and...

The Food and Drug Administration awarded a purchase order to Euromonitor International, Inc. for $879,485.00 on August 12, 2020 to provide access to sales data and information reports on hookah, cigars, electronic nicotine delivery systems, smokeless tobacco, and cigarettes. Performance is based in Chicago, Illinois. The contractor delivers six customized reports annually, plus one additional report per year covering emerging new tobacco products, summarizing sales by product category,...